YieldMax AMZN Option Income Strategy ETF vs 10X Genomics Inc — how do they compare? YieldMax AMZN Option Income Strategy ETF trades at $11.28, while 10X Genomics Inc trades at $56.98 (market cap $7.61B). The key difference: 10X Genomics Inc is trading nearer its 52-week high, YieldMax AMZN Option Income Strategy ETF nearer its low. Which is the better fit depends on your goals.
| AMZY | TXG | |
|---|---|---|
Sector | Income / Options Overlay | Health |
52-Week High | $15.75 | $58.57 |
52-Week Low | $9.98 | $11.34 |
Market Cap | — | $7.61B |
Enterprise Value | — | $7.14B |
Signals from Pluang's Aura AI — not financial advice
AMZY trades at $11.35, down 2.32% today, with a bullish technical signal from moving averages but neutral oscillators. The ETF has paid consistent weekly dividends, with recent distributions ranging from $0.06 to $0.14 per share. Key resistance and support levels are clustered around $12 and $11, respectively, indicating a tight trading range.
Outlook is cautious due to concerns over NAV erosion from its synthetic option strategy, as highlighted by Seeking Alpha. While high yields attract income seekers, the strategy may cap upside and amplify downside risk. Investors should weigh the income benefits against potential long-term underperformance relative to Amazon.
TXG (10x Genomics) trades at $56.95, down 2.77% on the day. The stock exhibits bullish technical signals with strong moving averages, though RSI levels suggest overbought conditions. Fundamentally, the company shows improving trends with Q2 2026 earnings beating estimates and a narrowing net loss margin from -41.23% in 2023 to -12.18% in 2026. Recent news highlights collaborations with Cleveland Clinic and acquisition of Proteintech Genomics, expanding multiomics capabilities.
Outlook: Growth potential exists through market expansion and innovation, but risks include persistent unprofitability and high valuation multiples. Analyst sentiment is mixed with a $46 consensus target below current price, indicating caution despite recent operational improvements.
Trailing returns across standard periods
AMZY is an actively managed ETF that seeks to generate monthly income by selling call options on Amazon (AMZN) stock. It aims to provide high yield while maintaining exposure to the price movements of the e-commerce giant.
Read more on AMZY →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →